首页 | 本学科首页   官方微博 | 高级检索  
     


Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis,treatment and follow-up2
Affiliation:1. Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health University of Brescia, ASST-Spedali Civili, Brescia, Italy;2. State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Shatin, Hong Kong, Special Administrative Region, People''s Republic of China;3. Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori and University of Milan, Milan, Italy;4. Department of Research, Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy;5. Radiation Oncology Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy;6. Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Faculty of Medicine, Masaryk University, Brno, Czech Republic;7. Department of Otorhinolaryngology Head and Neck Surgery, University Hospital Essen, Essen, Germany;8. Sorbonne University, APHP, Department of ENT – Head and Neck Surgery, Tenon Hospital, Paris, France;9. Department of ENT – Head and Neck Surgery, Erasmus Medical Center Rotterdam, Rotterdam;10. Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute, Amsterdam, the Netherlands;11. Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands;12. Administration Board of Centro Hospitalar e Universitário do Algarve, Portugal;13. Institut Roi Albert II, Service d''Oncologie Médicale, Cliniques Universitaires Saint-Luc, Brussels, Belgium;14. Institut de Recherche Clinique et Expérimentale (POLE MIRO), Université Catholique de Louvain, Brussels, Belgium
Abstract:
Keywords:nasopharyngeal cancer  Clinical Practice Guidelines  diagnosis  treatment  follow-up
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号